Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation

MeSH terms

• Adult
• Antibodies, Monoclonal, Murine-Derived / therapeutic use*
• Antineoplastic Agents / therapeutic use*
• Chronic Disease
• Female
• Graft vs Host Disease / drug therapy
• Humans
• Immunosuppressive Agents / therapeutic use
• Lymphoma, Follicular / drug therapy*
• Lymphoma, Follicular / pathology
• Lymphoma, Follicular / prevention & control*
• Recurrence
• Remission Induction
• Rituximab
• Stem Cell Transplantation / adverse effects*
• Transplantation Conditioning / adverse effects*
• Transplantation, Homologous / adverse effects*